ProQR Therapeutics NV News - PRQR | ADVFN

Register for real-time alerts, custom portfolio, and market movers

Get Started

Home
Investing
Stocks
USA
NASDAQ
ProQR Therapeutics NV (PRQR)
ProQR Therapeutics NV (PRQR) News

ProQR Therapeutics NV (PRQR)

1.71

0.00

(0.00%)

Closed June 23 4:00PM

Delayed by 15 minutes

1.71

0.00

(0.00%)

After Hours: 6:20PM

Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form SC 13G - Statement of acquisition of beneficial ownership by individuals

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549FORM 6-KReport of Foreign Private...

Notice of Effectiveness (effect)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 NOTICE OF EFFECTIVENESSEffective Date:April 24, 2023...

1
Next

Monksdream

Monksdream 2 months ago

PonkenPlonken

PonkenPlonken 2 months ago

added 2.01 hoping for love from LLY, 4bln in milestones.

glenn1919

glenn1919 3 months ago

PRQR.....................................https://stockcharts.com/h-sc/ui?s=PRQR&p=W&b=5&g=0&id=p86431144783

glenn1919

glenn1919 3 months ago

PRQR............................https://stockcharts.com/h-sc/ui?s=PRQR&p=W&b=5&g=0&id=p86431144783

Monksdream

Monksdream 4 months ago

Monksdream

Monksdream 9 months ago

AJ Freely

AJ Freely 11 months ago

$PRQR - 👆Up 7.3% Pre-Market/ Current Price $1.65
Announce Agreement for Théa to Acquire ProQR’s Sepofarsen and Ultevursen Ophthalmic Assets

KeepOn

KeepOn 1 year ago

Alan Brown

Alan Brown 1 year ago

Alan Brown

Alan Brown 1 year ago

subslover

subslover 2 years ago

Eli Lilly sends ProQR 35% higher after expanding RNA editing deal

https://seekingalpha.com/news/3919739-prqr-stock-surges-as-eli-lilly-expands-rna-editing-deal

TommyBoyTrader9460

TommyBoyTrader9460 2 years ago

$PRQR Strong break up the chart..on watch next week

https://stockcharts.com/c-sc/sc?s=PRQR&p=D&b=5&g=0&i=0&r=1668863394516

MADDSTACKER

MADDSTACKER 2 years ago

Time for a bounce … I hope :)

KeepOn

KeepOn 2 years ago

$4 is the lowest consensus I can find here:
https://etfdailynews.com/news/proqr-therapeutics-nasdaqprqr-pt-lowered-to-8-00/

What say you?

Also, when do we know it stopped dropping?

jaggerxj6

jaggerxj6 2 years ago

....looking for a 80 cent deadcat bounce?????

swampboots

swampboots 2 years ago

PRQR holding steady in market colapse odds are for up in 3 days.

swampboots

swampboots 2 years ago

PRQR 1.38 start.

stockguard

stockguard 2 years ago

ProQR Therapeutics SCHEDULE 13G 02/04/2022
Amended: It`s a boy!!!!!!!!! Really they only missed a 100,000 shares bought by Wellington Management Group LLP that is runs a lot of Vanguard and ETF funds.....
https://www.streetinsider.com/SEC+Filings/Form++SC+13GA+++ProQR+Therapeutics+N.V.++++++++++++++++Filed+by%3A+WELLINGTON+MANAGEMENT+GROUP+LLP/19559743.html

JohnLocke101

JohnLocke101 3 years ago

JohnLocke101

JohnLocke101 3 years ago

Important area here for PRQR in the 8.40ish resistance. Hopefully we can get a volume surge.

JohnLocke101

JohnLocke101 3 years ago

Some Nov/Dec call options with $10 strike traded today.. time for the pps to get up there. Looking stable going into 2022. Q 1/2 will be big.

JohnLocke101

JohnLocke101 3 years ago

Im liking the setup. Come on PRQR, make the move. Bollinger says we’re close.

MADDSTACKER

MADDSTACKER 3 years ago

Lilly earnings tomorrow wonder if we get a mention

JohnLocke101

JohnLocke101 3 years ago

Investment Case On ProQR Therapeutics Gets More Enticing

murocman

murocman 3 years ago

Looks like the high 7’s are even better! Man somebody took the air out of this balloon today.

Murocman

JohnLocke101

JohnLocke101 3 years ago

Low $8’s is a great place to add, me thinks.

MADDSTACKER

MADDSTACKER 3 years ago

JohnLocke101

JohnLocke101 3 years ago

Yep. Editas data validated PRQR. Continued new highs coming.

Good Luck!

MADDSTACKER

MADDSTACKER 3 years ago

News out , nice volume

MADDSTACKER

MADDSTACKER 3 years ago

JohnLocke101

JohnLocke101 3 years ago

I see indications that PRQR is about to make a move up. We’ll see..

MADDSTACKER

MADDSTACKER 3 years ago

Mind if I ask what you saw ?

JohnLocke101

JohnLocke101 3 years ago

I think options activity is getting interesting.

MADDSTACKER

MADDSTACKER 3 years ago

What do you think of these guys ? Seems like $50 at some point ?

JohnLocke101

JohnLocke101 3 years ago

Oops. Sorry about that.

Oligonucleotides to treat eye disease

MADDSTACKER

MADDSTACKER 3 years ago

Is that for prqr ?

JohnLocke101

JohnLocke101 3 years ago

MADDSTACKER

MADDSTACKER 3 years ago

Anyone else felling a break out coming ?

JohnLocke101

JohnLocke101 3 years ago

Eli Lilly takes 5.6% stake in PRQR according to 13g

JohnLocke101

JohnLocke101 3 years ago

Personally, I think it gets swooped up before then.

Anyone else load up under $8 for another round?

Good Luck!

MADDSTACKER

MADDSTACKER 3 years ago

Need some 2023 calls

JohnLocke101

JohnLocke101 3 years ago

Been fun today. Even as quiet as this board is.

Sub 8 now, they’re giving it away, so adding big.. again.

Good Luck!

JohnLocke101

JohnLocke101 3 years ago

“QR-421a was observed to be well tolerated at all doses in participants with exon 13 mutations in USH2A. QR-421a demonstrated encouraging evidence of disease stabilization in visual acuity and clinically significant improvements in retinal sensitivity, supported by objective retinal structural imaging data, after a single dose compared with UE and SE. An open-label extension trial is planned to follow up the Stellar trial participants, and 2 Phase 2/3 trials are planned."

JohnLocke101

JohnLocke101 3 years ago

JohnLocke101

JohnLocke101 3 years ago

ProQR Therapeutics teams up with Eli Lilly in potential $1.25B research collaboration

JohnLocke101

JohnLocke101 3 years ago

Added the dip, sub $7

JohnLocke101

JohnLocke101 3 years ago

Vicious little eod rally. Hrmm..

JohnLocke101

JohnLocke101 3 years ago

Looking good leading up to the fireside chat.

JohnLocke101

JohnLocke101 3 years ago

Is it finally time to take the next leg up? Looking promising..

Microlytics

Microlytics 3 years ago

Get ready boys and girls, this can rip at any time

ProQR Therapeutics NV

Daqo New Energy

Delayed Upgrade Clock